Firm-Wide blog

Will New Warnings Protect Victims from Morcellator Injuries?

By Burg Simpson
August 27, 2015
2 min read

Among the more appalling medical controversies in the past few years is the power morcellator scandal. This surgical technique involves the use of a power tool that can actually spread cancer in certain instances. Morcellators have been widely used as a minimally invasive procedure to remove uterine fibroids, which are growths that some women develop during childbearing years. The laparoscopic procedure involves the use of a morcellator to break up masses and remove them through a small tube. However, if there are cancerous cells involved, these dangerous cells can be spread very quickly to other organs and tissues.

Lawsuits vindicate victims and their families

The women who have been harmed by surgery with morcellators and their families may be entitled to recovery against the manufacturers of these dangerous surgical devices. These devices have robbed countless families of loving mothers and wives, leaving children and spouses devastated. While no amount of money can alleviate the pain of losing a loved one, grieving families should not be saddled with additional financial burdens in addition to the crushing grief and emotional struggles that the unjust death of a loved one can leave.

FDA warns against using morcellators

In the words of the U.S. Food and Drug Administration (FDA), “If laparoscopic power morcellation is performed in [women with unsuspected uterine sarcoma], there is a risk that the procedure will spread the cancerous tissue within the abdomen and pelvis, significantly worsening the patient’s likelihood of long-term survival.” Based on this risk, the FDA has instituted a “black box” announcement on morcellator devices, warning “against using laparoscopic power morcellators in the majority of women undergoing myomectomy or hysterectomy and recommend[ing] doctors share this information with their patients.”

Safer alternatives

According to the FDA, morcellator-related procedures are only appropriate for a “narrow population” of women. This demographic includes younger women seeking to maintain their ability to have children who agree to the procedure despite being informed of the risks morcellators pose. As alternatives, the FDA recommends several other procedures, including conventional surgical hysterectomies and surgeries using smaller incisions.

Free case evaluation form